LT2017504A - Method for characterizing of malignat tissues of spectral intercellular fluid analyses - Google Patents

Method for characterizing of malignat tissues of spectral intercellular fluid analyses

Info

Publication number
LT2017504A
LT2017504A LT2017504A LT2017504A LT2017504A LT 2017504 A LT2017504 A LT 2017504A LT 2017504 A LT2017504 A LT 2017504A LT 2017504 A LT2017504 A LT 2017504A LT 2017504 A LT2017504 A LT 2017504A
Authority
LT
Lithuania
Prior art keywords
spectral
intercellular fluid
characterizing
tissues
malignat
Prior art date
Application number
LT2017504A
Other languages
Lithuanian (lt)
Other versions
LT6574B (en
Inventor
Valdas ŠABLINSKAS
Gerald Steiner
Feliksas JANKEVIČIUS
Milda PUČETAITĖ
Vidita URBONIENĖ
Martynas VELIČKA
Justinas ČEPONKUS
Original Assignee
Vilniaus Universitetas
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vilniaus Universitetas filed Critical Vilniaus Universitetas
Priority to LT2017504A priority Critical patent/LT6574B/en
Publication of LT2017504A publication Critical patent/LT2017504A/en
Publication of LT6574B publication Critical patent/LT6574B/en

Links

Landscapes

  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)

Abstract

The invention is related to methods for characterizing malignant tissues and in particular to method for characterizing of malignant tissues of spectral intercellular fluid analyses. The method for identification of malignant cells specific spectral markers comprises recording a background spectrum of an optical fiber probe (1) without an intercellular fluid sample (2); providing the intercellular fluid sample (2) on the full internal reflection prisms of the optical fiber probe (1); drying of the sample (2) with air; recording the spectral absorption spectrum of the intercellular fluid sample in the spectral domain of 4000 - 600 cm; performing spectrum analysis in the spectral region from 1200 to 1000 cm-1.
LT2017504A 2017-03-30 2017-03-30 Method for characterizing of malignat tissues of spectral intercellular fluid analyses LT6574B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
LT2017504A LT6574B (en) 2017-03-30 2017-03-30 Method for characterizing of malignat tissues of spectral intercellular fluid analyses

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
LT2017504A LT6574B (en) 2017-03-30 2017-03-30 Method for characterizing of malignat tissues of spectral intercellular fluid analyses

Publications (2)

Publication Number Publication Date
LT2017504A true LT2017504A (en) 2018-10-10
LT6574B LT6574B (en) 2018-12-27

Family

ID=63719265

Family Applications (1)

Application Number Title Priority Date Filing Date
LT2017504A LT6574B (en) 2017-03-30 2017-03-30 Method for characterizing of malignat tissues of spectral intercellular fluid analyses

Country Status (1)

Country Link
LT (1) LT6574B (en)

Also Published As

Publication number Publication date
LT6574B (en) 2018-12-27

Similar Documents

Publication Publication Date Title
WO2007090147A3 (en) Method and apparatus for measurement of optical properties in tissue
ES2701092T3 (en) Procedures, kits and systems for scoring the immune response to cancer by simultaneous detection of CD3, CD8, CD20 and FOXP3
Canetta et al. Modulated Raman spectroscopy for enhanced identification of bladder tumor cells in urine samples
Sanden et al. The use of Fourier‐transform infrared spectroscopy to characterize connective tissue components in skeletal muscle of Atlantic cod (Gadus morhua L.)
MX2019000411A (en) Reduced false positive identification for spectroscopic classification.
MX2018008421A (en) Methods for treating cancer and the use of biomarkers as a predictor of clinical sensitivity to therapies.
EA201290766A1 (en) X-RAY FLUORESCENT ANALYZER
ATE360809T1 (en) RAPID TEST FOR BIOLOGICAL SUBSTANCES USING FTIR
ATE536553T1 (en) METHOD FOR DETECTING MAJOR ADVERSE CARDIOVASCULAR AND CEREBROVASCULAR EVENTS
ATE503846T1 (en) METHOD FOR DIAGNOSIS OF OVARIAL CARCINOMA
MX360341B (en) Method and device for identifying jewellery and gems.
MX2017006097A (en) Fluid characterization of porous materials libs.
WO2011046597A8 (en) Biomarkers and identification methods for the early detection and recurrence prediction of breast cancer using nmr
AR071034A1 (en) USE OF CATEPSIN C IN THE DIAGNOSIS OF SUSCEPTIBILITY TO PAIN AND FOR THE TREATMENT OF PAIN
EA201691497A1 (en) METHODS OF DETECTION AND QUANTITATIVE DETERMINATION OF IMITATORS OF CIRCULATING TUMOR CELLS
MX2015013993A (en) Methods and arrays for use in biomarker detection for prostate cancer.
LT2017504A (en) Method for characterizing of malignat tissues of spectral intercellular fluid analyses
GB2517865A (en) Real time optical detection of bacteria
Chen et al. Estimating the voice source in noise.
AR067158A1 (en) DEVICE AND METHOD FOR ANALYZING A VINIFICATION LIQUID
Shen et al. Accurate and noninvasive embryos screening during in vitro fertilization (IVF) assisted by Raman analysis ofembryos culture medium
CN107741412A (en) It is a kind of that serum analysis instrument is frozen based on the ultraviolet Raman fluorescence Spectra of time domain resolution
ATE495432T1 (en) ANALYSIS DEVICE OR METHOD FOR INVESTIGATION OF THE CATALYTIC ACTIVITY OF SURFACES
AR091096A1 (en) SPECTRAL ANALYSIS TECHNIQUES BASED ON SPECTRAL MONITORING OF A MATRIX
Brustmann p40 as a basal cell marker in the diagnosis of prostate glandular proliferations: a comparative immunohistochemical study with 34betaE12

Legal Events

Date Code Title Description
BB1A Patent application published

Effective date: 20181010

FG9A Patent granted

Effective date: 20181227

MM9A Lapsed patents

Effective date: 20210330